Mascagni Wealth Management Inc. Buys 298 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Mascagni Wealth Management Inc. lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,918 shares of the financial services provider’s stock after purchasing an additional 298 shares during the quarter. Mascagni Wealth Management Inc.’s holdings in iShares Biotechnology ETF were worth $254,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Eagle Strategies LLC grew its position in iShares Biotechnology ETF by 10.2% during the first quarter. Eagle Strategies LLC now owns 12,800 shares of the financial services provider’s stock worth $1,637,000 after buying an additional 1,181 shares in the last quarter. Valmark Advisers Inc. grew its position in iShares Biotechnology ETF by 57.8% during the first quarter. Valmark Advisers Inc. now owns 2,434 shares of the financial services provider’s stock worth $311,000 after buying an additional 892 shares in the last quarter. WealthCare Investment Partners LLC grew its position in iShares Biotechnology ETF by 16.1% during the first quarter. WealthCare Investment Partners LLC now owns 12,012 shares of the financial services provider’s stock worth $1,408,000 after buying an additional 1,664 shares in the last quarter. Garde Capital Inc. purchased a new position in iShares Biotechnology ETF during the first quarter worth about $36,000. Finally, Canton Hathaway LLC grew its position in iShares Biotechnology ETF by 45.2% during the first quarter. Canton Hathaway LLC now owns 14,461 shares of the financial services provider’s stock worth $1,850,000 after buying an additional 4,500 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 0.5%

IBB opened at $124.94 on Tuesday. The stock has a 50-day moving average price of $123.06 and a 200-day moving average price of $129.70. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $150.57.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.